FDA Clears Abionic’s IVD CAPSULE PSP for the early detection of Sepsis  Epalinges, Switzerland, October 01, 2024 – Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to accelerate the